We are live on
!
Find out more
VC
Vestor Capital Portfolio holdings
AUM
$1.59M
1-Year Est. Return
51.04%
This Fund
S&P 500
This Quarter
Est. Return
-11.81%
1 Year Est. Return
+51.04%
3 Year Est. Return
+186.4%
5 Year Est. Return
+293.28%
10 Year Est. Return
–
AUM
$825M
AUM Growth
-$183M
(-18%)
Cap. Flow
-$42.8M
Cap. Flow
% of AUM
-5.19%
Top 10 Holdings %
Top 10 Hldgs %
34.8%
Holding
245
New
15
Increased
44
Reduced
54
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$13.2M |
| 2 |
Elevance Health
ELV
|
+$12.3M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$12.2M |
| 4 |
LyondellBasell Industries
LYB
|
+$12.1M |
| 5 |
Cencora
COR
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$22.5M |
| 2 |
Microsoft
MSFT
|
+$21.2M |
| 3 |
Bank of America
BAC
|
+$13.5M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$12.1M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.33% |
| 2 | Technology | 14.33% |
| 3 | Industrials | 10.33% |
| 4 | Financials | 7.08% |
| 5 | Materials | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares MSCI EAFE ETF
EFA
$76.4B
| $12.1M | 1.47% |
194,128
-4,329
| -2% | -$295K |
|
27
SLB Ltd
SLB
$72.7B
| $11.9M | 1.44% |
333,084
+132,714
| +66% | +$5.54M |
|
|
28
Alphabet (Google) Class C
GOOG
$4.11T
| $11.8M | 1.43% |
107,760
-190,680
| -64% | -$22.5M |
|
|
29
Cencora
COR
$62B
| $11.1M | 1.35% |
+78,791
| New | +$12.1M |
|
30
Home Depot
HD
$337B
| $11.1M | 1.35% |
40,553
-15,653
| -28% | -$4.62M |
|
|
31
Bank of America
BAC
$429B
| $10.8M | 1.32% |
348,549
-373,778
| -52% | -$13.5M |
|
32
Johnson & Johnson
JNJ
$640B
| $9.34M | 1.13% |
52,624
+194
| +0.4% | +$34.6K |
|
33
Nutrien
NTR
$33.9B
| $9.18M | 1.11% |
+115,164
| New | +$11.2M |
|
34
JPMorgan Chase
JPM
$916B
| $9.18M | 1.11% |
81,484
+15,582
| +24% | +$1.93M |
|
35
Devon Energy
DVN
$51.3B
| $8.85M | 1.07% |
+160,562
| New | +$10.5M |
|
36
ConocoPhillips
COP
$144B
| $8.49M | 1.03% |
94,536
-172
| -0.2% | -$17.7K |
|
37
Prologis
PLD
$136B
| $8.42M | 1.02% |
71,576
+299
| +0.4% | +$41.3K |
|
38
Procter & Gamble
PG
$340B
| $8.03M | 0.97% |
55,867
+195
| +0.4% | +$29.3K |
|
39
McDonald's
MCD
$193B
| $7.69M | 0.93% |
31,157
+10,188
| +49% | +$2.51M |
|
40
Cardinal Health
CAH
$53.7B
| $7.65M | 0.93% |
+146,354
| New | +$8.32M |
|
41
Vanguard Real Estate ETF
VNQ
$39.9B
| $7.63M | 0.92% |
83,707
-810
| -1% | -$80.7K |
|
42
IQVIA
IQV
$40.7B
| $7.06M | 0.86% |
32,523
+25
| +0.1% | +$5.43K |
|
43
AutoZone
AZO
$51.3B
| $6.92M | 0.84% |
3,222
+40
| +1% | +$82.3K |
|
44
Dow Inc
DOW
$22B
| $6.53M | 0.79% |
+126,447
| New | +$8.1M |
|
|
VPU
45
Vanguard Utilities ETF
VPU
$8.56B
| $6.45M | 0.78% |
42,337
-362
| -0.8% | -$57K |
|
46
Waste Management
WM
$95B
| $5.91M | 0.72% |
38,655
-120
| -0.3% | -$18.8K |
|
47
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| $5.8M | 0.7% |
139,239
+11,091
| +9% | +$479K |
|
48
Medtronic
MDT
$112B
| $5.69M | 0.69% |
63,409
+6
| +0% | +$608 |
|
49
CVS Health
CVS
$135B
| $5.37M | 0.65% |
57,969
+117
| +0.2% | +$11.4K |
|
50
iShares MSCI Emerging Markets ex China ETF
EMXC
$22.1B
| $5.1M | 0.62% |
106,703
+70,719
| +197% | +$3.76M |
|
Similar funds
DILIH
DF
HGCK
AI
SH
CAM
SCM
CAGAS
Vestor Capital's Q2 2022 Portfolio in Review
As of Q2 2022, Vestor Capital held 245 positions worth $825M, down 18% from $1.01B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Vestor Capital withdrew a net $42.8M in Q2 2022, closing 36 positions and reducing 54 holdings. Its most notable exit was Upstart Holdings, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
Against the trend, Vestor Capital opened a new position in Cencora worth $11.1M.
- Vestor Capital's largest Q2 2022 buy was Cencora: 78,791 shares worth $11.1M.
- Vestor Capital added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022, an estimated $13.2M increase.
- Vestor Capital's biggest Q2 2022 reduction was Alphabet (Google) Class C, cutting an estimated $22.5M.
- Vestor Capital fully exited Upstart Holdings in Q2 2022, selling an estimated $10.9M.
- Vestor Capital's ten largest holdings make up 35% of its $825M portfolio in Q2 2022.
- Vestor Capital opened 15 new positions and closed 36 in Q2 2022.
- Vestor Capital's portfolio value fell 18% quarter-over-quarter to $825M.
Based on Vestor Capital's 13F filing for Q2 2022, filed 10 Aug 2022.